Tackling the spread of drug-resistant tuberculosis in Europe

The Lancet

Volumn 379, Issue 9813, 2012, Pages

  Abubakar, Ibrahim ^a,e   Dara, Masoud ^b   Manissero, Davide ^c   Zumla, Alimuddin ^d  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b WHO REGIONAL OFFICE FOR EUROPE   (Denmark)

^c EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^e UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

DISEASE TRANSMISSION; ESTONIA; EUROPE; HEALTH CARE ACCESS; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; LATVIA; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NOTE; PRIORITY JOURNAL; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

EID: 84856377900     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)61428-1     Document Type: Note

References (12)

1. NR Gandhi, P Nunn, K Dheda et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis Lancet 375 2010 1830 1843
2. WHO Global tuberculosis control 2010 http://www.who.int/tb/publications/ global-report/2010/en/index.html (accessed Sept 5, 2011).
3. European Centre for Disease Prevention and Control/WHO Tuberculosis surveillance in Europe 2009 http://www.ecdc.europa.eu/en/publications/ Publications/Forms/ECDC-DispForm.aspx?ID=660 (accessed Sept 5, 2011).
4. R Fears, S Kaufmann, V Ter Meulen, A Zumla Drug-resistant tuberculosis in the European Union: opportunities and challenges for control Tuberculosis (Edinb) 90 2010 182 187
5. ME Kruijshaar, JM Watson, F Drobniewski et al. Increasing antituberculosis drug resistance in the United Kingdom: analysis of national surveillance data BMJ 336 2008 1231 1234 (Pubitemid 351809318)
6. A Wright, M Zignol, A Van Deun et al. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance Lancet 373 2009 1861 1873
7. J Veen, P de Colombani WHO regional office for Europe. Review of the national tuberculosis programme in Ukraine http://www.euro.who.int/-data/assets/ pdf-file/0007/142369/e95006.pdf Oct 10-22, 2010 (accessed Sept 5, 2011).
8. T Cohen, M Murray Modeling epidemics of multidrug-resistant M tuberculosis of heterogeneous fitness Nat Med 10 2004 1117 1121 (Pubitemid 39424874)
9. WHO European Region The consolidated action plan to prevent and combat multidrug- and extensively drug-resistant tuberculosis in the WHO European Region 2011-2015. Sept 12-15, 2011. EUR/RC61/Inf.Doc/3 2011 WHO Copenhagen
10. 62nd World Health Assembly Prevention and control of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis. WHA62.15. 8th plenary meeting, May 22, 2009. A62/VR/8 http://www.who.int/tb/features-archive/wha62-15- tb-resolution/en/index.html (accessed Sept 5, 2011).
11. TR Frieden, PI Fujiwara, RM Washko, MA Hamburg Tuberculosis in New York City - turning the tide N Engl J Med 333 1995 229 233
12. Department of Health Stopping tuberculosis in England: Chief Medical Officer's action plan 2004 COI Communications for the Department of Health London